GE Healthcare 12RL ECG Quick Guide - Manual

GE Healthcare
12RL ECG
Reconstructed 12-lead
ECG Monitoring
Quick Guide
What is 12RL technology?
Continuous ECG monitoring requires a balance of
patient comfort, monitoring information and clinician
workload. More electrodes on the patient result in
more information being available to the clinician.
However, this may result in patient comfort and
clinician workload being compromised. The value of
12-lead ECG monitoring, requiring 10 electrodes,
is in its ability to detect arrhythmias and acute
myocardial ischemia.
1
Placing 10 electrodes on a patient often requires
too much work when compared with the benefi t
and extra maintenance required. Sometimes it can
even be impossible due to treatment the patient has
already received or is due to receive.
The 12RL ™ technology provides 12-lead view,
12-lead ST monitoring and global QT/QTc interval
measurement using a reduced leadset. It means only
six electrodes in standard placement (RA, RL, LA, LL,
V1 and V5) are required.
Additionally, reports state “leads V2, V3, V4 and V6 are
interpolated” to clarify that these leads are not directly
acquired. 12RL reports do not contain interpretations
of rhythm, morphology or classifi cation.
A view of a 12RL report on the monitor screen
As with all patient monitoring, 12RL ECG needs to
be used in conjunction with the patient’s clinical
history, symptoms and other diagnostic tests for
clinical judgement. 12RL ECG is intended for use in
the general adult patient population in a monitoring
environment.
1) Drew, B. J. Celebrating the 100th birthday of the
electrocardiogram: Lessons learned from research in
cardiac monitor. American Journal of Critical Care 11, No. 4
(July 2002)
2) Drew, B. J., et. al. Comparison of a new reduced lead
set ECG with the standard ECG for diagnosing cardiac
arrhythmias and myocardial ischemia. Journal of
Electrocardiology
35, (Supplement 2002)
© 2010 General Electric Company – All rights reserved.
GE, GE Monogram, 12RL and 12SL are trademarks of
General Electric Company
General Electric Company reserves the right to make changes
in specifications and features shown herein, or discontinue the
product described at any time without notice or obligation.
Contact your GE representative for the most current information.
GE Healthcare Finland Oy, doing business as GE Healthcare.
CAUTION: U.S. Federal law restricts this device to sale by or on the
order of a licensed medical practitioner.
Consult the monitor User’s Guide for detailed instructions.
About GE Healthcare
GE Healthcare provides transformational medical technologies
and services that are shaping a new age of patient care. Our
broad expertise in medical imaging and information technolo-
gies, medical diagnostics, patient monitoring systems, drug
discovery, biopharmaceutical manufacturing technologies,
performance improvement and performance solutions services
help our customers to deliver better care to more people around
the world at a lower cost. In addition, we partner with healthcare
leaders, striving to leverage the global policy change neces-
sary to implement a successful shift to sustainable healthcare
systems.
Our “healthymagination” vision for the future invites the world to
join us on our journey as we continuously develop innovations
focused on reducing costs, increasing access and improving
quality and effi ciency around the world.
GE Healthcare
P.O. Box 900, FIN-00031 GE, Finland
Tel. +358 10 394 11
Fax +358 9 146 3310
www.gehealthcare.com
EMEA M1205735/0410
Global version DOC0506506 Rev2